BV vs CBZ
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
BV
60.1
AI Score
VS
BV Wins
CBZ
53.1
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | BV | CBZ | Winner |
|---|---|---|---|
| Revenue | 1.77B | 1.53B | BV |
| Net Income | -4.14M | 171.39M | CBZ |
| Gross Margin | 26.0% | 19.5% | BV |
| Net Margin | -0.2% | 11.2% | CBZ |
| Operating Income | 13.91M | 218.58M | CBZ |
| ROE | -0.6% | 9.2% | CBZ |
| ROA | -0.1% | 3.7% | CBZ |
| Total Assets | 2.92B | 4.57B | CBZ |
| Cash | 16.43M | 20.90M | CBZ |
| Debt/Equity | 2.30 | 0.74 | CBZ |
| Current Ratio | 1.47 | 1.47 | CBZ |
| Free Cash Flow | 51.91M | 110.49M | CBZ |
Relative Price Performance (Last 90 Days)
BV 1M: -8.1%
· 3M: -28.4%
CBZ 1M: +0.5%
· 3M: +54.7%
Current Technical Phase
BV
MarkdownSell / avoid
Price below a falling SMA50 (slope -11.5%), weak momentum, RSI 41
CBZ
MarkupHold / add on dips
Price above SMA50, rising 50-day trend (14.5% over 20 days), RSI 72
Fundamentals Snapshot
| Metric | BV | CBZ |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 16.6 | 12.9 |
| Trailing P/E | — | 26.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.2% | 0.2% |
| Operating Margin | 0.0% | 0.0% |
| EPS | -0.24 | 2.08 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, BV is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.